Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

People with alopecia have a higher risk of thyroid cancer.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Diet can influence inflammatory skin diseases.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Lowering testosterone speeds up wound healing in male mice.

Blocking interferon-gamma might help treat various autoimmune diseases.

Deep skin fibroblasts help recruit immune cells for better wound healing.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The WNT signaling pathway is crucial for mesenchymal stem cells' function and therapy success.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Nrf2 helps protect skin from damage but too much can cause skin problems.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.